Hospital@Home: Telemedical Care After Inpatient Hospital Stay

NCT ID: NCT05617560

Last Updated: 2025-04-11

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 234 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2022-10-26
• Study Completion Date: 2024-12-31

Brief Summary

This pilot study is to investigate a patient transfer path from the hospital to Hospital@Home to their general practitioners (GPs) using telemedical procedures. Telemedical support will be executed by Medgate who will refer the patients to their GPs after the telemedical consultations are completed. Inclusion criteria is the need for short time follow up procedures that can be handled by telemedicine. Throughout the study, patient and stakeholder satisfaction will be measured and data-based methods will be developed to assess patient transfer success. Overall, new information flow and communication between the stakeholders (hospital, telemedicine and general practitioners) are defined and tested. The Hospital@Home pilot study is intended to become a flagship project for new healthcare models.

Detailed Description

This pilot study is to investigate a patient transfer path from the hospital to Hospital@Home to their general practitioners (GPs) using telemedical procedures.

The following study procedures are depicted:

Visit 1 (screening): Patients provide the name of their GP, the means of transport that they usually take to him, demographic data, past medical history and current medications.

The study team contacts the GP afterwards by phone to get his/her consent. The study team informs Medgate about the participant and the procedure. Next to that it will link Medgate technically to the case of the patient that Medgate can see the patient's documentation in the University Hospital Basel (USB) -ePortal.

Visit 2 (transfer): Before leaving the hospital, the participant will be instructed by a member of the study team on how and when to fill out the questionnaires. At this time, the participant and the USB physician will answer the first one. After Medgate has received the information from USB that the patient has been included in the study and has left the hospital, the patient will be contacted by Medgate and the appointment for the first teleconsultation will be made according to information from USB. The patient will be called by Medgate physician at the agreed time and the teleconsultation will be performed. Depending on the patient's condition and health status, further appointments are scheduled. The patient has the possibility to contact Medgate at any time (24/7) in case of an urgent medical matter. The patient receives the physician's recommendations in written form after each teleconsultation as their treatment plan via app or e-mail.

Visit 3...x (telecare): In advance of the first consultation via Medgate, the Medgate physician will log in into the USB-ePortal to get all important medical information about the patient. After that consultation the patient and the Medgate physician will answer a questionnaire. Depending on the clinical condition, health status and from this resulted procedure, the participant will be contacted several times. After the last consultation the Medgate physician will answer a questionnaire and will refer the patient back to the GP. The documentation will be sent to the GP and the USB. The GP will get a questionnaire as well.

Visit 4 (follow-up): On day x after the last consultation via Medgate the GP and the participant will answer the last questionnaire.

Conditions

Telemedicine

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: HEALTH_SERVICES_RESEARCH
• Blinding Strategy: NONE

Study Groups

Telemedical care

Group Type: EXPERIMENTAL

Telemedical care

Intervention Type: OTHER

Telemedical care will be provided to all participants after stationary hospital stay. This care will be in form of telephone consultations and / or videocall consultations with a medical physician. Depending on the individual medical history and the planned aftercare and procedure of the participants it will comprise of one or more such telephone consultations.

Interventions

Telemedical care

Telemedical care will be provided to all participants after stationary hospital stay. This care will be in form of telephone consultations and / or videocall consultations with a medical physician. Depending on the individual medical history and the planned aftercare and procedure of the participants it will comprise of one or more such telephone consultations.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Written informed consent as documented by signature from the patient
• Planned hospital discharge
• Intended follow-up care, that is manageable with telemedicine

Exclusion Criteria

• Significant mental or cognitive impairment
• Unable or not willing to sign informed consent
• Unable to understand German
• No possibility of telecommunication or use of such (app or phone)

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Innosuisse - Swiss Innovation Agency

OTHER

Sponsor Role: collaborator

University Hospital, Basel, Switzerland

OTHER

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Jens Eckstein, Prof. Dr. med.

Role: PRINCIPAL_INVESTIGATOR

University Hospital Basel, Division of Internal Medicine

Locations

University Hospital Basel, Division of Internal Medicine

Basel, , Switzerland

Countries

Switzerland

Other Identifiers

2022-01440; am22Eckstein2

Identifier Type: -

Identifier Source: org_study_id